Although mRNA expression of IL-17 in the lung tissue of BLM-induced pulmonary fibrosis was not affected by kurarinone or PFD treatment, kurarinone at a higher dose (10 mg/kg) significantly inhibited IL-17 production at the protein level. The gene discussed is IL17A; the disease is pulmonary fibrosis.